Clinical significance of abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondyloarthropathies

European Journal of Nuclear Medicine

Volumn 27, Issue 12, 2000, Pages 1768-1773

  Alonso Farto, J C ^a   Almoguera Arias, I ^a   Lopez Longo, F J ^a   Gonzalez Fernandez, C M ^a   Monteagudo Saez, I ^a   Ortega Valle, A ^a   Bascones, M ^a   Perez Vazquez J M ^a   Carreno Perez L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

99mTc HMPAO labelled leucocyte scintigraphy; Abdominal scintigraphy; Silent gut inflammation; Spondyloarthropathy

Indexed keywords

C REACTIVE PROTEIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL SCINTISCANNING; ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; FEMALE; HUMAN; INFLAMMATION; ISOTOPE LABELING; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; SEROLOGY; SPONDYLOARTHROPATHY; ULCERATIVE COLITIS;

ABDOMEN; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HLA-B27 ANTIGEN; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LEUKOCYTES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SPONDYLITIS; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0033635863     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000393     Document Type: Article

References (36)

1. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
2. Gut inflammation in the spondyloarthropathies: Clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study
3. The germfree state prevents development of gut and joint inflammatory disease in HLA-B 27 transgenic rats
4. Bowel inflammation and the spondyloarthropathies
5. Different abdominal scintigraphy pattern in patients with ulcerative colitis, Crohn's disease and seronegative spondylarthropathies
6. 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease
7. Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel disease
8. Technetium-99m HMPAO-labelled leukocytes in detection of inflammatory lesions: Comparison with gallium-67 citrate
9. Manual de procedimientos radiofarmaceuticos 'Marcaje de leucocitos con HMPAO'
10. Seronegative spondylarthropathies A. Epidemiology, pathology and pathogenesis
11. Sulphasalazine in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis
12. Evaluation of sulphasalazine in ankylosing spondylitis
13. HLA-B 27 related arthritis and bowel inflammation. II. Ileocolonoscopy and bowel histology in patients with HLA-B 27 related arthritis
14. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis
15. Course of gut inflammation in spondylarthropathies and therapeutic consequences
16. Systematic ileocolonoscopy and bowel biopsy in spondylarthropathy
17. Macroscopic and microscopic gut lesions in seronegative spondylarthropathies
18. Ileocolonoscopic and histological studies in Korean patients with ankylosing spondylitis
19. High frequency of silent inflammatory bowel disease in spondylarthropathy
20. Clinically silent gut lesions in undifferentiated spondyloarthropathies
21. Gut inflammation in psoriatic arthritis: A prospective ileocolonoscopic study
22. The evolution of spondylarthropathies in relation to gut histology. I. Prospective study of the clinical spondylarthropathy
23. Repeat ileocolonoscopy in reactive arthritis
24. Specificity of Tc-99m-HMPAO-labelled leukocyte uptake in the large bowel as an indicator of inflammatory bowel disease
25. Technetium-99m hexamethyl propylene amine oxime leukocytes in the assessment of disease activity in inflammatory bowel disease
26. Intestinal permeability in ankylosing spondylitis
27. Spontaneous inflammatory disease in transgenic rats expressing HLA-B 27 and human beta2-m: An animal model of HLA-B 27-associated human disorders
28. Positive abdominal scintigraphy in patients with spondyloarthropathy: What is the morphological significance?
29. Intestinal mucosal permeability in inflammatory rheumatic diseases. 2. Role of disease
30. Increased numbers of IgG-containing cells in rectal lamina propria of patients with ankylosing spondylitis
31. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: Dissection of the molecular mechanisms
32. Anatomic predilection of the spondyloarthropathies: A case of the nerves?
33. Evidence for a specific B 27-associated cell surface marker in lymphocytes of patients with ankylosing spondylitis
34. Demonstration of cross-reactivity between bacterial antigens and class I human leukocyte antigens by using monoclonal antibodies to Shigella flexneri
35. Yersinia enterocolitica serotype O:3 Alters the expression of serologic HLA-B27 epitopes on human monocytes
36. Seronegative spondyloarthropathies and subclinical gut inflammation: Clinical course and abdominal scintigraphic changes in treated patients